A Part of the University of Maryland Medical Center

Connect with UMGCC
Facebook Twitter YouTube Blog iPhone
Email PageEmail page Print PagePrint page

UMGCC NEWS

The University of Maryland Marlene and Stewart Greenebaum Cancer Center Receives Highest Rating in Cancer Care

Commission on Cancer of the American College of Surgeons Recognizes Multidisciplinary, Integrated, and Comprehensive Oncology Services

CoC Logo

The University of Maryland Marlene and Stewart Greenebaum Cancer Center (UMGCC) has received the highest level of award given by the Commission on Cancer of the American College of Surgeons in 2012, a three-year award with commendation.

Oncology programs earning recognition from the Commission on Cancer (CoC) of the American College of Surgeons offer high-quality cancer care. Only one in four hospitals that treat cancer receives this special approval. It recognizes the quality of comprehensive cancer care available at a facility and offers a commitment that patients will have access to all of the various medical specialists who are involved in the diagnosis and treatment of cancer.

Recognizing that cooperation between specialists results in improved patient outcomes, UMGCC has been a leader in the multidisciplinary approach to providing pretreatment evaluation, staging, treatment and follow-up care for patients with all types of cancer. Patients meet with, and are treated by, teams of specialists from surgical, medical and radiation oncology as part of integrated multidisciplinary clinics located in the Stoler Pavilion outpatient center for cancer care. Each patient's case is also reviewed and discussed by the team of experts -- including pathologists, diagnostic radiologists, and other cancer specialists -- in weekly multidisciplinary clinic conferences.

Approval by the Commission on Cancer is given only to those facilities that have voluntarily committed to provide the best in diagnosis and treatment of cancers. To meet the standards necessary for Commission approval, each cancer program must undergo a rigorous evaluation process and a review of its leadership, cancer data management, patient care, research, community outreach and quality improvement. In order to maintain approval, facilities with approved cancer programs must undergo an on-site review every three years.

The University of Maryland Marlene and Stewart Greenebaum Cancer Center is a nationally recognized leader in cancer diagnosis, treatment and research. With comprehensive programs for treating all types of cancer, it is a major referral center for patients in Maryland and throughout the region. For more information, please call 800-888-8823.


This page was last updated on: June 5, 2012.